Rights and permissions
About this article
Cite this article
Fondaparinux dominates enoxaparin sodium for non-ST-segment elevation acute coronary syndromes in French hospital setting. Inpharma Wkly. 1604, 6 (2007). https://doi.org/10.2165/00128413-200716040-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200716040-00011